ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 109 filers reported holding ANI PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,142,083 | +16.6% | 88,565 | +8.1% | 0.00% | +33.3% |
| Q2 2023 | $4,411,692 | +44.9% | 81,956 | +6.9% | 0.00% | +50.0% |
| Q1 2023 | $3,043,784 | -2.5% | 76,631 | -1.2% | 0.00% | 0.0% |
| Q4 2022 | $3,121,607 | +23.2% | 77,594 | -1.6% | 0.00% | 0.0% |
| Q3 2022 | $2,534,000 | -8.0% | 78,843 | -15.1% | 0.00% | 0.0% |
| Q2 2022 | $2,755,000 | +11.4% | 92,879 | +5.6% | 0.00% | 0.0% |
| Q1 2022 | $2,472,000 | -31.1% | 87,927 | +13.0% | 0.00% | 0.0% |
| Q4 2021 | $3,586,000 | +65.4% | 77,830 | +17.8% | 0.00% | +100.0% |
| Q3 2021 | $2,168,000 | -9.9% | 66,056 | -3.8% | 0.00% | -50.0% |
| Q2 2021 | $2,406,000 | -11.0% | 68,646 | -8.2% | 0.00% | 0.0% |
| Q1 2021 | $2,702,000 | +25.5% | 74,758 | +0.8% | 0.00% | 0.0% |
| Q4 2020 | $2,153,000 | +0.1% | 74,151 | -2.8% | 0.00% | 0.0% |
| Q3 2020 | $2,151,000 | -11.2% | 76,262 | +1.8% | 0.00% | 0.0% |
| Q2 2020 | $2,422,000 | -26.4% | 74,905 | -7.2% | 0.00% | -50.0% |
| Q1 2020 | $3,289,000 | -36.2% | 80,721 | -3.4% | 0.00% | 0.0% |
| Q4 2019 | $5,155,000 | -8.7% | 83,596 | +7.9% | 0.00% | -20.0% |
| Q3 2019 | $5,648,000 | -3.9% | 77,492 | +8.4% | 0.01% | 0.0% |
| Q2 2019 | $5,875,000 | +24.9% | 71,469 | +7.2% | 0.01% | +25.0% |
| Q1 2019 | $4,702,000 | +55.1% | 66,662 | -1.0% | 0.00% | +33.3% |
| Q4 2018 | $3,031,000 | -19.8% | 67,326 | +0.8% | 0.00% | 0.0% |
| Q3 2018 | $3,777,000 | -20.0% | 66,797 | -5.5% | 0.00% | -25.0% |
| Q2 2018 | $4,723,000 | +18.1% | 70,700 | +2.9% | 0.00% | 0.0% |
| Q1 2018 | $3,999,000 | -7.5% | 68,687 | +2.4% | 0.00% | 0.0% |
| Q4 2017 | $4,322,000 | +21.8% | 67,057 | -0.8% | 0.00% | +33.3% |
| Q3 2017 | $3,547,000 | +24.1% | 67,579 | +10.6% | 0.00% | 0.0% |
| Q2 2017 | $2,858,000 | -14.8% | 61,078 | -9.9% | 0.00% | -25.0% |
| Q1 2017 | $3,356,000 | -16.1% | 67,783 | +2.7% | 0.00% | -20.0% |
| Q4 2016 | $4,001,000 | +4.8% | 65,994 | +14.7% | 0.01% | 0.0% |
| Q3 2016 | $3,818,000 | +28.0% | 57,545 | +7.7% | 0.01% | +25.0% |
| Q2 2016 | $2,983,000 | +71.0% | 53,447 | +3.1% | 0.00% | +33.3% |
| Q1 2016 | $1,744,000 | -22.7% | 51,821 | +3.7% | 0.00% | 0.0% |
| Q4 2015 | $2,255,000 | +19.8% | 49,979 | +4.9% | 0.00% | 0.0% |
| Q3 2015 | $1,882,000 | -39.4% | 47,624 | -4.9% | 0.00% | -40.0% |
| Q2 2015 | $3,106,000 | -2.2% | 50,064 | -1.5% | 0.01% | 0.0% |
| Q1 2015 | $3,177,000 | – | 50,804 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANGROVE PARTNERS IM, LLC | 326,778 | $20,152,000 | 2.95% |
| Hawk Ridge Capital Management | 188,761 | $11,641,000 | 1.89% |
| Global Alpha Capital Management Ltd. | 169,746 | $10,468,000 | 1.55% |
| Mesirow Financial Investment Management, Inc. | 5,723 | $353,000 | 1.49% |
| 1492 Capital Management LLC | 25,093 | $1,547,000 | 1.37% |
| THB ASSET MANAGEMENT | 91,018 | $5,613,000 | 1.04% |
| Regent Investment Management LLC | 41,329 | $2,549,000 | 0.78% |
| Phocas Financial Corp. | 101,567 | $6,263,000 | 0.75% |
| INVESTMENT COUNSELORS OF MARYLAND LLC | 284,334 | $17,535,000 | 0.75% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 35,500 | $2,189,000 | 0.70% |